Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Allarity Therapeutics (ALLR) Revenue (2024 - 2025)

Allarity Therapeutics' Revenue history spans 2 years, with the latest figure at -$59000.0 for Q4 2025.

  • For Q4 2025, Revenue rose 21.33% year-over-year to -$59000.0; the TTM value through Dec 2025 reached -$185000.0, up 71.67%, while the annual FY2025 figure was $320000.0, N/A changed from the prior year.
  • Revenue reached -$59000.0 in Q4 2025 per ALLR's latest filing, down from -$57000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of -$12000.0 in Q2 2025 to a low of -$426000.0 in Q2 2024.